Dr. Tracey McLaughlin graduated from Stanford University with honors and distinction in Human Biology, obtained a MS in Public Health at UC Berkeley, and MD at UC San Francisco. She completed her residency in Internal Medicine at Santa Clara Valley Medical Center and her fellowship in Endocrinology, Diabetes, and Metabolism at Stanford University School of Medicine. She is currently a clinician investigator who maintains an active clinic for patients with complicated type 1, type 2, or other forms of diabetes, polycystic ovarian disease, and hypoglcyemia. Her clinical research program includes human studies on obesity, regional fat distribution, and the role of adipocytes and adipose tissue immune cells in promoting insulin resistance and type 2 diabetes. She also conducts studies on the role of incretin hormones in glucose metabolism and postbariatric hypoglycemia, and the use of continuous glucose monitoring and multi-omics methods to define metabolic sub-phenotypes and precision diets for individuals with prediabetes and type 2 diabetes.

Dr. McLaughlin conducts clinical research related to obesity, insulin resistance, diabetes, and cardiovascular disease (CVD). Current studies include:

1. the impact of macronutrient composition on metabolism, DM2 and CVD;
2. comparison of different weight loss diets on metabolism and CVD risk reduction;
3. role of adipocytes and adipose tissue immune cells in modulating insulin resistance;
4. use of continuous glucose monitoring and multi-omics to define metabolic phenotype and precision diets